Acura Pharmaceuticals reported -387000 in Net Income for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Acelrx Pharmaceuticals ACRX:US $ -8.38M 1.48M
Acura Pharmaceuticals ACUR:US -387000 128K
Intra Cellular Therapies ITCI:US $ -76.91M 8.16M
Johnson & Johnson JNJ:US $ 3667M 2611M
Nektar Therapeutics NKTR:US $ -129.71M 4.19M
Pfizer PFE:US $ 8146M 2582M
Rigel Pharmaceuticals RIGL:US $ -20.95M 7.13M
Shionogi 4507:JP Y 20893M 11344M
Sun Pharmaceuticals SUNP:IN IR 20470.1M 6028.4M
Teva Pharmaceutical TEVA:IT 290M 83M
Xeris Pharmaceuticals Inc XERS:US -26009000 1.51M
Zogenix ZGNX:US $ -58M 0.89M